1. Cardiovascular microphysiological systems (CVMPS) for safety studies – a pharma perspective. Issue 3 (20th January 2021) Authors: Pointon, Amy; Maher, Jonathan; Davis, Myrtle; Baker, Thomas; Cichocki, Joseph; Ramsden, Diane; Hale, Christopher; Kolaja, Kyle L.; Levesque, Paul; Sura, Radhakrishna; Stresser, David M.; Gintant, Gary Journal: Lab on a chip Issue: Volume 21:Issue 3(2021) Page Start: 458 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
2. Current and future approaches to nonclinical cardiovascular safety assessment. Issue 7 (July 2020) Authors: Collins, Teresa A.; Rolf, Michael G.; Pointon, Amy Journal: Drug discovery today Issue: Volume 25:Issue 7(2020) Page Start: 1129 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
3. Drug-induced myocardial dysfunction – recommendations for assessment in clinical and pre-clinical studies. Issue 3 (3rd March 2020) Authors: Ebrahimi, Ahmad; Raichlen, Joel S; Pointon, Amy; Gottfridsson, Christer; Munley, Jiefen; Hockings, Paul; Cartwright, James; Buss, Nicholas; Wikström, Johannes; Gan, Li-Ming; Whittaker, Andrew; Khalil, Ali; George, Richard T; Garkaviy, Pavlo; Brott, David Journal: Expert opinion on drug safety Issue: Volume 19:Issue 3(2020) Page Start: 281 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
4. Intra- and intercellular signaling pathways associated with drug-induced cardiac pathophysiology. (August 2021) Authors: Guo, Fei; Hall, Andrew R.; Tape, Christopher J.; Ling, Stephanie; Pointon, Amy Journal: Trends in pharmacological sciences Issue: Volume 42:Number 8(2021) Page Start: 675 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
5. Investigating signaling mechanisms of structural cardiotoxicity via in situ single cell analysis by TOBis IMC on heterocellular cardiac organoids. (31st December 2022) Authors: Guo, Fei; Hall, Andew; Ling, Stephanie; Tape, Christopher; Pointon, Amy Journal: Journal of molecular and cellular cardiology Issue: Volume 173(2022)Supplement Page Start: 167 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
6. Time for a Fully Integrated Nonclinical–Clinical Risk Assessment to Streamline QT Prolongation Liability Determinations: A Pharma Industry Perspective. Issue 2 (24th September 2020) Authors: Vargas, Hugo M.; Rolf, Michael G.; Wisialowski, Todd A.; Achanzar, William; Bahinski, Anthony; Bass, Alan; Benson, Charles T; Chaudhary, Khuram W.; Couvreur, Nicolas; Dota, Corina; Engwall, Michael J; Michael Foley, C.; Gallacher, David; Greiter‐Wilke, Andrea; Guillon, Jean‐Michel; Guth, Brian; H... Journal: Clinical pharmacology & therapeutics Issue: Volume 109:Issue 2(2021) Page Start: 310 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
7. Time for a Fully Integrated Nonclinical–Clinical Risk Assessment to Streamline QT Prolongation Liability Determinations: A Pharma Industry Perspective. Issue 2 (24th September 2020) Authors: Vargas, Hugo M.; Rolf, Michael G.; Wisialowski, Todd A.; Achanzar, William; Bahinski, Anthony; Bass, Alan; Benson, Charles T; Chaudhary, Khuram W.; Couvreur, Nicolas; Dota, Corina; Engwall, Michael J; Michael Foley, C.; Gallacher, David; Greiter‐Wilke, Andrea; Guillon, Jean‐Michel; Guth, Brian; H... Journal: Clinical pharmacology & therapeutics Issue: Volume 109:Issue 2(2021) Page Start: 310 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
8. Use of non-invasive reflective biomarkers to monitor 3D cardiac microtissue viability and toxicity. (20th October 2017) Authors: Basak, Jayati; Barnes, Jennifer; Pointon, Amy; Archer, Caroline Journal: Toxicology letters Issue: Volume 280(2017)Supplement 1 Page Start: S160 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗